Trial Profile
Multicenter Observational Program Evaluation of the Efficacy and Tolerability of Detralex Treatment in Patients With Chronic Venous Edema (CEAP Class С3) in Real Clinical Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jan 2023
Price :
$35
*
At a glance
- Drugs S 5682 (Primary)
- Indications Oedema
- Focus Therapeutic Use
- Acronyms VAP-PRO-C3
- Sponsors Servier
- 14 Apr 2022 Status changed from recruiting to completed.
- 14 Oct 2019 Planned End Date changed from 10 Jun 2019 to 10 Dec 2019.
- 10 Jan 2019 Status changed from not yet recruiting to recruiting.